In adult men with autism spectrum disorder, 6-week intranasal oxytocin significantly reduced core symptoms of social reciprocity on the ADOS compared with placebo.
In plain wordsIn adult men with autism, six weeks of nasal oxytocin lowered social reciprocity symptom scores compared with placebo.
- Peptide
- Oxytocin
- Outcome
- DecreaseADOS social reciprocity score
- Study
n = 18
- Comparator
- Placebo
- Analysis
- Exploratory
- Outcome group
- Autism core symptoms · Mental health and mood
- Studied dose
- Dose not stated · intranasal · 6 weeksAs given in this study (human).
Source sentences
Data obtained from 18 participants who completed the trial showed that 6-week intranasal administration of oxytocin significantly reduced autism core symptoms specific to social reciprocity, which was clinically evaluated by Autism Diagnostic Observation Scale (P = 0.034, PFDR < 0.05, Cohen's d = 0.78).
1 context sentence(design, population, supporting numbers)
Here, to address this issue, we performed an exploratory, randomized, double-blind, placebo-controlled, crossover trial including 20 high-functional adult males with autism spectrum disorder.